Today: 7 February 2026
Subscribe
Browse Category

Legal News News 2 February 2026 - 7 February 2026

Johnson & Johnson stock rises on talc-court ruling — FDA Class I recall keeps JNJ in focus

Johnson & Johnson stock rises on talc-court ruling — FDA Class I recall keeps JNJ in focus

JNJ shares rose 0.9% to $239.99 in after-hours trading. A New Jersey appeals court barred Beasley Allen from representing plaintiffs in state talc cases against J&J, citing ethical concerns. The FDA announced a Class I recall for certain CEREPAK detachable coil systems sold by J&J’s MedTech unit, linked to four injuries and one death.
7 February 2026
····
Johnson & Johnson stock ticks up on talc-case ruling as FDA recall adds new wrinkle

Johnson & Johnson stock ticks up on talc-case ruling as FDA recall adds new wrinkle

A New Jersey appeals court barred Beasley Allen from representing plaintiffs in state talc lawsuits against Johnson & Johnson, prompting the firm to plan an appeal. J&J shares edged up 0.2% to $238.34 by midday. The FDA issued its most serious recall for certain CEREPAK detachable coil systems, citing risks of severe injury or death.
6 February 2026
·····
Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent shares traded near $30.36 premarket Friday, just below IBM’s $31-per-share cash offer, after the company filed new merger disclosures with the SEC in response to shareholder demand letters and lawsuits. Confluent will report earnings Feb. 11 but will not hold a call or forecast while the IBM deal remains pending. The shareholder vote is set for Feb. 12.
6 February 2026
····
Uber stock price today: UBER steadies after earnings, as robotaxi push meets fresh legal risk

Uber stock price today: UBER steadies after earnings, as robotaxi push meets fresh legal risk

Uber shares rose 1.7% to $75.21 in after-hours trading Thursday after reporting Q4 gross bookings of $54.1 billion, up 22%. The company announced a CFO transition and plans to expand robotaxi operations to up to 15 cities by 2026. A federal jury ordered Uber to pay $8.5 million in a key rider-safety lawsuit. Uber’s Q1 profit outlook missed analyst estimates.
6 February 2026
····
JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

Johnson & Johnson shares rose 1.3% to $237.59 after the company asked the U.S. Supreme Court to review a shareholder lawsuit over talc safety claims. The petition challenges a Third Circuit ruling on class certification standards. The case is separate from ongoing talc injury suits. Investors are also watching for new data on J&J’s atrial fibrillation devices at a cardiology event this week.
5 February 2026
····
Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers Health shares surged to $29.44 before falling back to $24.41 after announcing $49 compounded semaglutide pills. Novo Nordisk said it will sue, calling the move illegal mass compounding. The FDA previously warned Hims about misleading claims on compounded semaglutide. Novo’s branded Wegovy pill will cost $199 per month.
5 February 2026
······
Verizon stock (VZ) closes higher after T-Mobile lawsuit — what traders watch next

Verizon stock (VZ) closes higher after T-Mobile lawsuit — what traders watch next

Verizon shares rose 1.6% to $47.01 Wednesday, extending a six-day rally as the company sued T-Mobile in Manhattan federal court for alleged false advertising over wireless savings claims. Trading volume hit 46.1 million shares. Verizon seeks triple damages and an injunction. T-Mobile did not immediately respond.
5 February 2026
······
Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase shares fell 6.2% to $168.62 in after-hours trading Wednesday after Nevada’s gaming regulator filed a civil enforcement action to block the company’s sports-linked event contracts. The Nevada Gaming Control Board seeks a court order halting what it calls unlicensed wagering. Coinbase called the move a “state power grab,” arguing federal law should apply. Bitcoin and ether also dropped, weighing on exchange stocks.
5 February 2026
·····
CoreWeave stock sinks below Nvidia deal price as lawsuit deadline comes into focus

CoreWeave stock sinks below Nvidia deal price as lawsuit deadline comes into focus

CoreWeave shares fell 3.6% to $85.71 by early afternoon Tuesday, dropping below the $87.20 price Nvidia paid for its recent stake. Securities-fraud class action notices resurfaced, with investors given until March 13 to seek lead plaintiff status. The stock slid alongside a broader pullback in AI and chip shares. The lawsuit cites alleged exaggerations of capacity and undisclosed construction delays.
3 February 2026
·····
CoreWeave stock slips as class-action notices pile up ahead of earnings

CoreWeave stock slips as class-action notices pile up ahead of earnings

CoreWeave shares fell 1.5% to $91.82 by midday Monday after new class action lawsuits alleged false statements and highlighted disclosure risks. Investors are awaiting the Feb. 18 earnings report for updates on capacity and spending. The stock faces pressure from litigation headlines and concerns over funding and delivery timelines. Nvidia and Microsoft also slipped, while Alphabet rose.
2 February 2026
······
1 2 3 … 14

Stock Market Today

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

7 February 2026
London, Feb 7, 2026, 08:20 GMT — Market closed. London Stock Exchange Group plc (LSEG.L) shares ended Friday at 7,502 pence, down about 1.1% on the day, with London markets shut for the weekend and set to reopen on Monday. (MarketWatch) The stock has been caught in a wider repricing of software, data and analytics names as investors question which business models benefit from the next wave of AI — and which get squeezed. “It’s a de-risking trade,” Andrew Wells, chief investment officer at SanJac Alpha, said, as he argued the AI build-out had become “too pricey.” (Reuters) LSEG also
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop